rs12988520
|
|
C |
0.800 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs17863787
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs2070959
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs4148325
|
|
C |
0.800 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs7564935
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Uganda Genome Resource Enables Insights into Population History and Genomic Discovery in Africa.
|
31675503 |
2019 |
rs929596
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population.
|
30621171 |
2019 |
rs28946889
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
rs6431630
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
rs8330
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
rs10178992
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs10179091
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs10929301
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs10929302
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11673726
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11695484
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs11888459
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs17862875
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs17863787
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs1875263
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs3755319
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs4148324
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs4148325
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |
rs4148325
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
We analyzed total bilirubin levels, which are linked to fatty liver in severe obesity, and observed the strongest evidence for association with rs4148325 in UGT1A (P < 5.0 × 10(-93)), replicating previous findings.
|
25246029 |
2015 |
rs4148325
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
|
26148204 |
2015 |
rs4663969
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
|
25884002 |
2015 |